Gland Pharma was founded by P V N Raju in 1978 and Fosun Pharma acquired 74 per cent stake in the company in 2017. Investor meeting with Sectoral Asset Management on 8th March 2021. Cultural shifts will drive healthcare habits in 2021, Chhattisgarh government plans to allow use of Covaxin in state: Minister, Ireland recommends suspending AstraZeneca jab over blood clot fears, PLI scheme incentive rate for medical sector should be revised to 10%: Transasia, Study reveals severity of Covid using imaging, Beijing makes getting visas easier for those who take China-made vaccines, More European nations suspend AstraZeneca vax use, Delhi: 1.6 lakh senior citizens among 7.2 lakh vaccinated; turnout on rise, Goa: Covid infections in state’s urban areas increasing, Embed ETHealthworld.com Widgets on your Website. Gland Pharma shares gain 38% over issue price; neat USFDA record, strong sales to further aid growth Gland Pharma works on a business to business model and … The deal, the largest purchase of an Indian asset by a Chinese company and the biggest inbound M&A so far this year, will allow Fosun to gain control of a new stable of injectable medicines as well as manufacturing facilities in India. Business Standard News: Check out Gland Pharma Financial Results, Quarterly Results (Q1, Q2, Q3, Q4) & Yearly Results & more financial news from Business Standard | Page 1 Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 37108.47 Crore) operating in Pharmaceuticals sector. Fosun has agreed to acquire 96 percent stake, which includes shares held by founders of Gland Pharma Ravi Penmetsa and family and private equity giant, KKR & Co LP. “Given Gland Pharma’s operation is in good condition, the founder shareholders propose to maintain a higher stake in Gland Pharma without impact on the acquisition of the controlling interest in Gland Pharma by Fosun Pharma Group, as well as expect to establish a closer cooperation with Fosun Pharma Group to jointly promote the sustainable and stable development of Gland Pharma,” Fosun said. All Rights Reserved. Coming from behind in a closely fought race that saw US giant Baxter and private equity fund Advent make firm offers early May, Hong Kong-listed Shanghai Fosun (Fosun Pharma) revised its offer last week to $1.27 billion. Approved by AICTE, PCI and Affiliated to JNTUH. Read latest news and live updates on Gland-pharma including breaking news on Gland-pharma,Gland-pharma photos,Gland-pharma videos and many more at cnbctv18.com. PETRONET 2.50%. WEB Intrinsic Value. Gland Pharma shares today rose as much as 20% to ₹ 2184 apiece, before closing 15% higher at ₹ 2091. The Board of Directors at its meeting held on January 22, 2021 has inter- alia approved the Unaudited Financial Results of the Company for the Quarter and Nine months ended December 31, 2020, Earnings Call for Investors/Analysts to be held on Friday, 22nd January, 2021 at 1830 hours IST, Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2021 ,inter alia, to consider and approve the Unaudited financial results of the Company for the quarter and nine months ended December 31, 2020, Analyst/ Investor meeting with Anand Rathi, Concept Investwell Pvt. Time And Venue Details: Walk-Ins On 17th March 2021 , 9:00 AM to 10:00 AM at Gland Pharma Ltd, APIIC, 3rd Phase, Plot No 42-52, Pashamylaram, Medak District. Gland Pharma’s IPO, consists of a fresh issue aggregating Rs 1,250 crore and an offer for sale (OFS) by existing shareholders and promoter of up to 3.49 crore equity shares. Tomorrow is different. Gland Pharma filed draft papers in July this year and obtained Sebi's observation on October 19, 2020, to float an IPO. 2016. The issue is priced at ₹1490 to ₹1500 per equity share. He said companies would reap the benefits of ecstatic primary and sound secondary market performances. The unique thing about Gland Pharma is that it is a B2B player in the complex injectable space with a profit … Gland Institute of Pharmaceutical Sciences establshed in 2009. Gland Pharma has seven manufacturing facilities in India. The company’s management has guided for a 15 per cent organic revenue growth in the pharma business for FY22 compared with the 1 per cent growth in the first nine months of FY21. ONGC -5.06%. The business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma companies. msn back to msn home news powered by Microsoft News Intrinsic value is the calculated value of the company and may differ from current stock price. Fosun has offered Fortis a funding of Rs 100 crore in 45 days and an investment of up to Rs 2,300 crore against a holding that will not extend beyond 25%. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to Rs. Amid cases of new variants of mutated SARS-CoV-2 emerging in India, it has become important to understand how the symptoms of different new variants vary from the original one. The equity shares of the company to be list at BSE, NSE. Portfolio. Overall, 10 shares were trading in green in Nifty50 index, while 40 were trading in red in the afternoon trade. Here's a word of advice for investors, Amid concerns over Covishield, India studies post-vaccination adverse events, Overcharged despite GST cut? Markets Today Top Gainers GICRE 19.98%. We use cookies to ensure the best experience for you on our website.If you choose to ignore this message, we'll assume that you are happy to receive all cookies on ET HealthWorld. (vi) As of March 31, 2020, Gland Pharma along with its partners had 265 ANDA filings in the United States, of which 204 were approved and 61 were pending approval. Gland Pharma Ltd News. Basic Pro. Find Gland Pharma Latest News, Videos & Pictures on Gland Pharma and see latest updates, news, information from NDTV.COM. ICICI Prudential Smallcap Fund Direct Plan-Growt.. ICICI Prudential Credit Risk Fund Direct Plan-Gr.. ICICI Prudential Asset Allocator Fund (FOF) Dire.. ICICI Prudential Balanced Advantage Direct-Growt.. ICICI Prudential Midcap Direct Plan-Growth. Get more Markets News and Business News on Zee Business. Fosun Pharma and Fosun International indirectly hold approximately 74 per cent equity interest in Gland Pharma, the joint statement added. In the latest December quarter, there were 19 IPOs valued at USD 1.836 billion and the largest was that of Gland Pharma with an issue size of USD 869 million. FRIENDS. The closing of the deal, which would be China's largest ever acquisition in India if approved, has now been extended to Sept. 26, the company added. Follow @ETHealthworld for the latest news, insider access to events and more. Will PSU disinvestment get a good response from retail investors? Gland Pharma was founded in 1978 to manufacture and market Heparin injection for the domestic market. Abhay Doshi, a Gujarat-based dealer of unlisted shares, believes the primary market has been on a roller-coaster ride of late. Dr Reddy's recalls around 70,000 vials of Zoledronic acid injection from US Pfizers’ global headquarters in the US is running a process to find suitors for the two factories, a 30 acre Sriperumbudur factory and a 50 acre plant in Aurangabad along with its plant and machinery. The Company will be attending the following mentioned Investor conference/event on 2nd and 3rd of March 2021 : Goldman Sachs annual India Pharma and Healthcare tour and Bernstein fireside chat with MD& CEO, Schedule of various Analyst/Investor meetings. The price band is in the range of Rs 1490 – Rs 1500 and the bid Lot is 10 Shares and in multiple thereof. Gland Pharma Ltd. GLAND. Gland Pharma Ltd. News. Gland Pharma's IPO … Account. Shanghai Fosun Pharmaceutical bids for sterile injectables maker Gland China’s Shanghai Fosun Pharmaceutical has made it official. Forex reserves fall by $4.255 billion to $580.299 billion. Ltd. and Kotak Institutional Equities on December 26 and 28, 2020. Biologics and biosimilar drugs are emerging hotspots, and Gland is arming itself to take a leap in this segment, which is estimated to be the around $30 billion globally. The Board of Directors on recommendation of the ESOP Compensation Committee of the Board of Directors of the Company has allotted 217,850 Equity shares of Rs.1/- each of the Company, fully paid-up, on January 22, 2021 to employees on exercise of their stock options pursuant to Gland Pharma Stock Options Scheme, 2019. Investment Checklist. Latest Share Price and Events. Post Issue the implied market cap of the company will be Rs 24337 cr – … Analyst / Investor Meet with HDFC Life Insurance on 18-Feb-2021, Analyst / Investor Meet with Premji Invest and Alchemy Capital on 15-Feb-2021, Details of Investor Conferences the Company plan to attend during the month of February 2021: Edelweiss India Annual e-Conference 2021 on Feb 9, 2021 and IIFL Securities - Global Investor Conference on Feb 25, 2021, Video/Tele - Conference - One on One with Nomura Asset Management on 17th February 2021, Tele/Video Conference - One on One meeting with Neuberger Berman Group LLC on 12-Feb-2021, Analyst / Investor Meet with Nippon India Mutual Fund and Pictet Asset Management UK Ltd. on 10-Feb-2021 and 11-Feb-2021, Tele/Video Conference - One on One meeting with Capital Research Global Investors on 10-Feb-2021, Tele/Video Conference - One on One meeting with Government Of Singapore on 3-Feb-2021, Tele/Video Conference - One on One with Goldman Sachs India SPL on 4-Feb-2021, Newspaper advertisement pertaining to Unaudited Financial Results of Q3 FY 2021, Tele/Video Conference - One on One meeting with Motilal Oswal Financial Services, Monitoring Agency Report dated January 22, 2021 in respect of utilization of proceeds of IPO for the quarter ended December 31, 2020 issued by M/s. Tridem has a sales network covering 21 French-speaking African countries and regions. Patancheru Mandal 502307. 163,500,673/- comprising of 163,500,673 Equity shares of face value Rs. Fosun targets Fortis: A white knight or a dark horse? Gland Pharma's IPO was subscribed 1.88 times as of 3:00 pm, according to information on National Stock Exchange's website. Copyright © 2021 Bennett, Coleman & Co. Ltd. All rights reserved. Gland Pharma Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2,490.90 0.00 (+0.00 %) Place Order. GLAND, BSE:543245- Keep track of all breaking news on Gland Pharma Ltd. from all sources at a single place. Stable Share Price: 543245 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 6% a week. The price band for the offer has been fixed at Rs 1,490-1,500 per share. We have updated our terms and conditions and privacy policy It entered the US market in 2007. Watchlist. Union Budget 2021 recognises the importance of health in India's growth story! While many analysts believe the stock is priced to perfection, some others project it to rise up to Rs 3,000, which would mean a 100 per cent return on the issue price. The 265 ANDA filings comprise 189 ANDA filings for sterile injectables, 50 for oncology and 26 for ophthalmics related products. We have various options to advertise with us including Events, Advertorials, Banners, Mailers, Webinars etc. PRINT Home. Gland Pharma is a Fresh Issue of Equity shares aggregating up to Rs 1250 Cr and Offer for sale of up to 3.48 cr Equity Shares. Place Order. It develops, manufactures and markets complex injectables. Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 37108.47 Crore) operating in Pharmaceuticals sector. 1/- each. India Business News: CHENNAI: Chinese pharmaceutical company Fosun Pharma-owned Gland Pharma has emerged a front runner to take over the two factories of Pfizer, one in Ch. There were just 11 IPOs in the year-ago period. Gland Pharma had informed that Fosun Pharma will be purchasing all the shares of the company owned by KKR Floorline Investments Pte Ltd, which amount to around 37%, in addition to shares of other shareholders of the company. Gland Pharma Ltd. and its shareholders are looking to raise as much as 64.5 billion rupees ($871 million) in what would be India’s biggest initial public offering by a pharmaceutical firm. Analyst / Investor Meet with IIFL Institutional Equities on 23-Dec-2020, Analyst / Investor Meet with Arohi Asset Management Pte. 7 states account for 87.73% of the new cases reported in a day9 hrs ago, Sun Pharma, Dr Reddy's, Aurobindo recall products in the US market14 hrs ago. Financially, Gland Pharma has reported healthy growth in annual profits. Mumbai: Gland Pharma’s initial public offer to raise Rs 6,480 crore got oversubscribed on the last day of thanks to Qualified Institutional Buyers (QIBs) as retail investors and non-institutional investors (NII) largely stayed away. Shares of the company are proposed to be listed on the BSE and the NSE. Please review and accept these changes below to continue using the website.You can see our privacy policy & our cookie policy. Sorry, there are no blogs for your search. The minimum order quantity is 10 Shares. Gland Pharma IPO is a main-board IPO of 43,196,968 equity shares of the face value of ₹1 aggregating up to ₹6,479.55 Crores. Get ETHealthworld's top stories every morning in your email inbox. Injectables are being preferred over oral delivery formats due to certain benefits offered such as convenience of administration. Dear user, ET HealthWorld privacy and cookie policy has been updated to align with the new data regulations in European Union. Axis Bank Limited, Monitoring Agency. Gland Pharma Limited (Gland) is an established player in the injectables space, which is one of the fastest-growing drug delivery formats across markets. The companies haven’t been formally notified yet of the move, the people said, asking not to be identified because the information is private. Location: Gland Pharma Ltd, Pashamylaram, Patancheru. New Delhi: Hyderabad-based pharma company Gland Pharma, owned by China's Fosun Pharma, is the first Chinese-owned pharma company seeking to raise Rs 6,480 crore from the primary markets through an initial public offer that opens today (November 9) and will close on November 11. 125000+ Industry Leaders read it everyday, How did you hear about us? Dr Reddy's Laboratories Inc is "recalling 59,468 vials of Zoledronic acid injection, 5mg/100 mL (0.05 mg/mL) 100ml vial," Enforcement Report of the United States Food and Drug Administration (USFDA) said. India said to block Fosun's $1.3 billion Gland purchase, India raises concerns around Chinese firm Fosun's takeover of Gland: Source, FIPB refers Gland Pharma proposal to CCEA for approval, FIPB green lights Gland Pharma’s acquisition by Shanghai Fosun, Dr Reddy's joins hands with Gland Pharma to market 8 ANDAs in US, Top PE firms join race for Claris Lifesciences’ US business, Fosun Signs $1.26-B Deal for Gland Buyout, China's Fosun to buy KKR backed Gland Pharma for $1.4 billion, Fosun leads the race to buy Gland Pharma with $1.27 billion bid, In Siddha, we steer the flow of energy via pressure points to remove chronic pain: Sathya Sindhuja, Chakrasiddh, Covaxin & Covishield now have the same intensity of licensure: Dr V K Paul, 8 of India’s 10 worst-hit dists in Maha, Centre ‘very worried’, Newer drugs for hypertension offer hope to kidney patients on World Kidney Day, Mapping the Road to Patient Safety with Incremental Innovation: An Insight, Demand for the natural products has increased substantially because of Covid-19: Girish Soman, Nisarga Herbs, Mumbai: BMC aims to add 47 pvt hosps, cover 30L priority popn in a mth, Need to maintain Indian Pharma’s export competitiveness with RoDTEP, Private Path Labs should play a role in Covid vaccination administration, A transformative approach for rare diseases, Denmark, Norway, Iceland suspend use of AstraZeneca vaccine, Expert panel recommends dropping ‘clinical trial mode’ tag for Covaxin, Dr Reddy's gets 3 observations from USFDA for US-based API plant, How symptoms of new Covid strains different from original one, Doctors urge people with comorbidities to take Covid-19 vaccine without hesitation, All above 60 years of age, 45-plus with other illnesses to get Covid-19 vaccine from March 1. Share Price & News. Get Gland Pharma Ltd. detailed news, announcements, financial report, company information, … The company plans to raise up to ₹1,250 crore through issue of … 18th May 2016 . May. Gland Pharma Limited is seeking approval for its initial acquisition of up to 86.08 per cent by Shanghai Fosun Pharmaceutical (Group) Company Limited. Ltd on 22-Dec-2020, Analyst / Investor meeting with Franklin Templeton Investments on 17-Dec-2020, Intimation of Institutional Investor Meeting, Investor Meetings (One on One) with various Investors, Gland Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended November 17, 2020. The IPO opens on Nov 9, 2020, and closes on Nov 11, 2020.. Link Intime India Private Ltd is the registrar for the IPO. For reprint rights: The Night of Ideas: 24 Hours Live to Feel "Closer", The Economic Times Digital Payments Forum, The Indian IPO that saw tepid bids 4 months ago is spinning money now, DHFL aside, pharma to drive Piramal stock, Buy Gland Pharma, target price Rs 2700: Motilal Oswal, Stellar show of stocks on debut pushes up grey market premiums, Stock market update: 78 stocks hit 52-week highs on NSE, Why technology is the only path to sustained growth for MSMEs, Ambani security scare: NIA arrests Mumbai cop Sachin Vaze, India signals backing for Russia on Ukraine issue at a UNSC meet, With all struggling, how did Adani's wealth rise by 50 pc, asks Rahul Gandhi, Bitcoin tops $16,000-mark!
University Of Alabama Mba Acceptance Rate, Town Of Huntington Garbage Phone Number, Bandz Headbands With Buttons, Chicago Real Gm, International Monetary System Conclusion, What Was The Areopagus Used For, Weather Cullman Al 10 Day, Iona Basketball Live Stream,
Deja una respuesta